PO-0771: Hypofractionated high-dose IMRT: effective and less toxic than 2D-RT in incurable head and neck cancer. (April 2015) - Van Beek, K.M.; Kaanders, J.H.A.M.; Janssens, G.O.R.J.; Takes, R.P.; Span, P.; Verhoef, C.G.